Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells. - Wikidata - wikimedia - TriplyDB

Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells.

Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells.

http://www.wikidata.org/entity/Q39990344

about

Silencing of p130cas in ovarian carcinoma: a novel mechanism for tumor cell death Targeting autophagy in cancer management - strategies and developments Autophagy and endocrine resistance in breast cancer Knockdown of PSMB7 induces autophagy in cardiomyocyte cultures: possible role in endoplasmic reticulum stress Toxicological considerations when creating nanoparticle-based drugs and drug delivery systems Autophagic cell death: the story of a misnomer Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy Antagonism of tumoral prolactin receptor promotes autophagy-related cell death.Heteroleptic mononuclear compounds of ruthenium(ii): synthesis, structural analyses, in vitro antitumor activity and in vivo toxicity on zebrafish embryos.Stimuli-Responsive Mesoporous Silica NPs as Non-viral Dual siRNA/Chemotherapy Carriers for Triple Negative Breast Cancer.Therapeutic Silencing of Bcl-2 by Systemically Administered siRNA Nanotherapeutics Inhibits Tumor Growth by Autophagy and Apoptosis and Enhances the Efficacy of Chemotherapy in Orthotopic Xenograft Models of ER (-) and ER (+) Breast Cancer.Cellular stress responses: cell survival and cell death C10ORF10/DEPP-mediated ROS accumulation is a critical modulator of FOXO3-induced autophagy.CD24 Expression and differential resistance to chemotherapy in triple-negative breast cancer.Cytotoxic autophagy in cancer therapy.Inhibition of active autophagy induces apoptosis and increases chemosensitivity in cholangiocarcinoma.Targeting autophagy in breast cancer.Down-regulation of 5-HT1B and 5-HT1D receptors inhibits proliferation, clonogenicity and invasion of human pancreatic cancer cells The importance of autophagy regulation in breast cancer development and treatment.Targeted silencing of elongation factor 2 kinase suppresses growth and sensitizes tumors to doxorubicin in an orthotopic model of breast cancer Elongation factor-2 kinase regulates TG2/β1 integrin/Src/uPAR pathway and epithelial-mesenchymal transition mediating pancreatic cancer cells invasion Downregulation of autophagy by Bcl-2 promotes MCF7 breast cancer cell growth independent of its inhibition of apoptosis.Silencing of the IKKε gene by siRNA inhibits invasiveness and growth of breast cancer cells.Autophagy: cancer's friend or foe?Autophagy as a therapeutic target in cancer.Autophagy induced by deficiency of sphingosine-1-phosphate phosphohydrolase 1 is switched to apoptosis by calpain-mediated autophagy-related gene 5 (Atg5) cleavage Andrographolide Analogue Induces Apoptosis and Autophagy Mediated Cell Death in U937 Cells by Inhibition of PI3K/Akt/mTOR Pathway.Neuronal cell death in neurodegenerative diseases: recurring themes around protein handling.Steroid receptor coactivator 3 regulates autophagy in breast cancer cells through macrophage migration inhibitory factor Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers.Bcl-2 confers survival in cisplatin treated cervical cancer cells: circumventing cisplatin dose-dependent toxicity and resistance Time depended Bcl-2 inhibition might be useful for a targeted drug therapy.Autophagy regulation in the development and treatment of breast cancer Targeted polymeric nanoparticles for cancer gene therapy.Removal of the BH4 domain from Bcl-2 protein triggers an autophagic process that impairs tumor growth.Tumor growth suppression by inhibiting both autophagy and STAT3 signaling in HNSCC.Endoplasmic reticulum stress sensitizes human esophageal cancer cell to radiation.Autophagy inhibition enhances apigenin-induced apoptosis in human breast cancer cells Is autophagy rather than apoptosis the regression driver in imatinib-treated gastrointestinal stromal tumors?Mullerian inhibiting substance suppresses proliferation and induces apoptosis and autophagy in endometriosis cells in vitro.

P2860

Q24632721-923ED758-51E3-4862-8AEA-F900E3CDF4EE Q26782468-511CD465-DC1A-492E-8AC9-007F0124D5ED Q27023375-50ABAA17-B584-4E8D-A999-0808F159A809 Q28297133-F798E367-8E41-4EC9-A811-D9BB696ECA71 Q28395046-3292680E-ECE9-4B63-B33D-6DE335D99DC7 Q29614564-D8181A99-15D7-43D1-AD20-DB20508B56DA Q30513775-6C4C435C-9962-4533-B57D-8E1AF2E32198 Q30579272-DB6F6899-4C91-41B2-B931-C612A702C699 Q31143548-60792165-6985-423B-B54F-9CED08DB6027 Q33635355-3D9C99C5-4661-4AB2-AACF-1C257328DAFA Q33637380-01F6D1EB-0FB4-4C62-8137-FAE3973C2519 Q33674213-B8231544-35CC-4C0B-9093-78665B1F3AF7 Q33730108-F3B5C8C8-27B7-4C9B-93B3-C5DD2C47BB0C Q33888775-AD42384E-EF7B-4515-8A4C-59228A8EE384 Q33907663-D270D3D2-74DE-48AD-8B8A-ADF81341D78A Q33925154-C2889FA0-F174-4D9F-96DF-7984EEE95E7A Q34023616-23261ACF-3CE0-44EA-AD4E-2D08B298B9FA Q34109699-EFFCD60D-011D-4719-9938-49BDB3E06599 Q34275855-3A72AEFC-D497-4943-B7B3-2A85FDA0CC12 Q34387697-A6304627-4121-4E62-9BB3-5463E19F03A1 Q34473662-D518A7E6-6F31-440F-88A9-43C43F312124 Q34474347-1ACECF49-5419-4CFC-9AD5-4440521D5708 Q34989052-22C65D67-BADD-4E4D-BE9F-DE8833954596 Q35146596-424A790B-DF4D-42D4-83BE-976B82214E91 Q35591562-9268F2BF-43F3-45BE-94B9-EA0358F8DDA6 Q35639764-C76A32E2-3815-42EC-A939-F852A13FECF2 Q35798939-57F0EB29-28E3-46B1-B9B8-E1C1911C1FC5 Q35886625-F8EADE38-E32E-4A7A-AEC2-B7378E5C3595 Q36009215-E6FA6F81-6DDD-4B7C-B33D-9E5CE9A99D82 Q36107033-7448FADB-D416-449C-8135-7DB0D5582DB2 Q36169503-CB688925-D027-43CF-AAC7-B8EB2019F47E Q36243019-5B836ABB-89F4-416E-A0E6-F8BD84D093BA Q36398762-D5D23A7B-4160-41B4-B274-2AB8D606C935 Q36416427-9794DC54-4F38-4E2E-9ED0-4D68248383FD Q36670905-931CBEEB-CA41-44A9-9724-9B82CAC5E6F7 Q36685448-946DC907-8C1C-4F07-A1D4-EF3E886321A4 Q36715054-F6E6E071-8FD7-4400-8469-3B5A8A4AA68B Q36767664-B72ABE33-4862-4602-9A1D-75180C519E92 Q36970527-7D62EF9D-3B40-403C-81A5-6A5DDFDB81E1 Q36989867-AE09EA70-1CD2-4ECE-8768-3232FF6ED95D

P2860

Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells.

http://www.wikidata.org/entity/Q39990344

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Silencing of Bcl-2 expression ...... in MCF-7 breast cancer cells.

@en

Silencing of Bcl-2 expression ...... in MCF-7 breast cancer cells.

@nl

type

label

Silencing of Bcl-2 expression ...... in MCF-7 breast cancer cells.

@en

Silencing of Bcl-2 expression ...... in MCF-7 breast cancer cells.

@nl

prefLabel

Silencing of Bcl-2 expression ...... in MCF-7 breast cancer cells.

@en

Silencing of Bcl-2 expression ...... in MCF-7 breast cancer cells.

@nl

P1433

Q39990344-647608A1-7BF9-4F24-B80D-7DBCAC45CA1A

P1476

Q39990344-630806FF-977C-4520-9949-5AF224422C38

P2093

Q39990344-1248AEA6-EBAD-4D79-AC91-36B18DB8615D

Q39990344-19AEAC7A-E1D1-4187-8EC3-D22762A4335B

Q39990344-439961A8-499B-47EF-8884-5BD4B88B60E1

Q39990344-4794FDEB-A887-474D-9CE0-06BB221D3CAB

Q39990344-56A47551-20B2-45E7-B20D-3996E4E7FFEB

Q39990344-5D4466CB-126F-412B-9845-0BCAFF0F869C

Q39990344-6AC41AE2-F786-457C-899D-98F146995FC2

Q39990344-959F3A2D-9609-4637-98D7-D15FF9184994

Q39990344-9775FEE4-8712-4BEB-AA0A-3FB92893D5B0

Q39990344-C870912C-C89D-4CB1-B3CE-77064FD7DB46

P304

Q39990344-0985A309-6BE7-4AE4-8F9A-A9F3D22287D3

P31

Q39990344-764321AB-6CA6-4204-BFAB-2DA2B625D20D

P356

Q39990344-85AC4ECC-1517-4AD1-B87A-6480A53A6F92

P433

Q39990344-B7F2628E-ED64-4EE7-871B-2363ECCA26DB

P478

Q39990344-830CB2DC-F5DD-4335-AD43-3E8EF40D8879

P577

Q39990344-507015A8-9BD3-4AF1-B6E6-FDCCA043EB3E

P5875

Q39990344-62DFFCE7-52CC-4CF8-A754-5C0B06995C2E

P698

Q39990344-75485106-C9B2-4C70-BEA2-8580D3CFC242

P921

Q39990344-021B6D0E-3300-4F4F-942C-E70ABDB763A2

P356

P1433

P1476

Silencing of Bcl-2 expression ...... in MCF-7 breast cancer cells.

@en

P2093

Ana Tari

http://www.w3.org/2001/XMLSchema#string

Angela Sanguino

http://www.w3.org/2001/XMLSchema#string

Arturo Chaves-Reyez

http://www.w3.org/2001/XMLSchema#string

Banu Arun

http://www.w3.org/2001/XMLSchema#string

Bulent Ozpolat

http://www.w3.org/2001/XMLSchema#string

Gabriel Lopez-Berestein

http://www.w3.org/2001/XMLSchema#string

Magaly Barria

http://www.w3.org/2001/XMLSchema#string

Seiji Kondo

http://www.w3.org/2001/XMLSchema#string

Ugur Akar

http://www.w3.org/2001/XMLSchema#string

Yasuko Kondo

http://www.w3.org/2001/XMLSchema#string

P304

669-679

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/AUTO.6083

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2008-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5427700

http://www.w3.org/2001/XMLSchema#string

P698

18424910

http://www.w3.org/2001/XMLSchema#string

P921